|Videos|May 11, 2020

Update on HER2-Targeted Therapy in Early Breast Cancer

Sara M. Tolaney, MD, MPH, discusses newer approaches to managing early stages of HER2+ breast cancer in both the neoadjuvant and adjuvant spaces.


Latest CME